RP-3500 (ATRi)
Showing 1 - 25 of 428
Solid Tumor, Metastatic Cancer Trial in United States (RP-3500, External Beam Radiotherapy (EBRT))
Recruiting
- Solid Tumor
- Metastatic Cancer
- RP-3500
- External Beam Radiotherapy (EBRT)
-
Basking Ridge, New Jersey
- +6 more
Dec 8, 2022
Chronic Lymphocytic Leukemia Trial in Salt Lake City (RP-3500 in combination with Olaparib)
Recruiting
- Chronic Lymphocytic Leukemia
- RP-3500 in combination with Olaparib
-
Salt Lake City, UtahHuntsman Cancer Institute at the University of Utah
Sep 23, 2022
PTSD, Alcohol Use Disorder Trial (Cognitive Processing Therapy + Relapse Prevention, Relapse Prevention)
Not yet recruiting
- Posttraumatic Stress Disorder
- Alcohol Use Disorder
- Cognitive Processing Therapy + Relapse Prevention
- Relapse Prevention
- (no location specified)
Jul 17, 2023
Recurrent Ovarian Cancer, Recurrent Uterine Cancer, Metastatic Cancer Trial in Toronto (RP-6306, Carboplatin, Paclitaxel)
Not yet recruiting
- Recurrent Ovarian Cancer
- +3 more
- RP-6306
- +2 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Oct 25, 2023
Advanced Stage Solid Tumors Trial in Sutton (M6620, Carboplatin, Paclitaxel)
Active, not recruiting
- Advanced Stage Solid Tumors
- M6620
- +2 more
-
Sutton, United KingdomRoyal Marsden NHS Foundation Trust
Feb 9, 2022
Migraine Trial in United States (Zavegepant (BHV3500), Placebo)
Completed
- Migraine
- Zavegepant (BHV3500)
- Placebo
-
Huntsville, Alabama
- +93 more
Dec 16, 2022
Retinitis Pigmentosa Trial in Ankara (Wharton's jelly derived mesenchymal stemcells, Magnovision)
Completed
- Retinitis Pigmentosa
- Wharton's jelly derived mesenchymal stemcells
- Magnovision
-
Ankara, Gölbaşı, Turkey
- +2 more
Mar 23, 2023
Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR
Not yet recruiting
- Pericarditis
- IL1RA Antibody Assay
- suPAR Testing
-
Homburg, Germany
- +8 more
Jun 22, 2023
Migraine Trial in United States (BHV-3500 (zavegepant), Placebo)
Recruiting
- Migraine
- BHV-3500 (zavegepant)
- Placebo
-
Phoenix, Arizona
- +99 more
Dec 16, 2022
Localized Prostate Cancer Participants Treated With Radical
Not yet recruiting
- High Risk Localized Prostate Cancer
-
Akita, JapanAkita University Hospital
Aug 2, 2022
Pathological Gambling, Internet Gaming Disorder Trial in Lund (Relaps Preventions Therapy, Treatment as usual)
Recruiting
- Pathological Gambling
- Internet Gaming Disorder
- Relaps Preventions Therapy
- Treatment as usual
-
Lund, SwedenChild and adolescent Clinic Rehion Skane
Aug 17, 2022
Rheumatoid Arthritis Trial in Lenexa, San Antonio, Salt Lake City (Test Product, Reference product, Reference Medicinal Product)
Recruiting
- Rheumatoid Arthritis
- Test Product
- +2 more
-
Lenexa, Kansas
- +2 more
Nov 8, 2023
Erectile Dysfunction Following Radical Prostatectomy Trial in Serdang (Low-Intensity Extracorporeal Shockwave Therapy (LiEWST) -
Recruiting
- Erectile Dysfunction Following Radical Prostatectomy
- Low-Intensity Extracorporeal Shockwave Therapy (LiEWST) - Active
- Low-Intensity Extracorporeal Shockwave Therapy (LiEWST) - Sham
-
Serdang, Selangor, MalaysiaHospital Sultan Abdul Aziz Shah, Universiti Putra Malaysia (prev
Oct 3, 2023
Retinitis Pigmentosa Trial in Worldwide (N-acetylcysteine, Placebo)
Not yet recruiting
- Retinitis Pigmentosa
- N-acetylcysteine
- Placebo
-
Davis, California
- +30 more
Sep 8, 2022
Deep Brain Stimulation, Parkinson Disease Trial in Shanghai (remote programming, standard programming)
Not yet recruiting
- Deep Brain Stimulation
- Parkinson Disease
- remote programming
- standard programming
-
Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicin
Oct 8, 2023
Prostate Cancer Trial in Calgary (Tai Chi Prehabilitation, Usual care)
Recruiting
- Prostate Cancer
- Tai Chi Prehabilitation
- Usual care
-
Calgary, Alberta, CanadaProstate Cancer Centre
Jul 8, 2022
PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM) Trial in La Jolla, Philadelphia (RP-A601)
Not yet recruiting
- PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
- RP-A601
-
La Jolla, California
- +1 more
May 22, 2023
Healthy Trial in Taichung (rice protein RP-80N, )
Active, not recruiting
- Healthy
- rice protein RP-80N
- placebo
-
Taichung, TaiwanChung Shan Medical University
Nov 25, 2022